Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New knee implant system tested for Second-Time replacement patients

NCT ID NCT03153475

Disease control Sponsor: DePuy Orthopaedics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 28, 2026 · Updated 4 times

Summary

This study is testing the ATTUNE Revision Knee System in 400 people who need a second knee replacement (revision surgery). The goal is to see how well the implant holds up over 5 years and how it affects patients' pain, function, and quality of life. Participants will be followed for 5 years after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ATTUNE Revision Knee System (a device used in revision knee replacement surgery)
What this could lead to
If successful, this could show that the ATTUNE Revision Knee System is a safe and effective option for people needing a second knee replacement, helping improve function and quality of life.
What could go wrong
This is an early-stage, non-randomized study with no comparison group, so results may not apply to everyone. The device may fail or cause complications, and long-term benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

400 people

The number who actually took part.

Started

May 2017

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria 1. Subject is male or female and between the ages of 22 and 80 years at the time of consent, inclusive. 2. Subject presents with a primary knee arthroplasty (primary TKA, unicompartmental) or prior revision TKA that requires a revision procedure of implanted tibial and/or femoral components. 3. The decision to perform a knee revision with the study device is regardless of the research. 4. Subject that is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor 5. Subject is currently not bedridden 6. The devices are to be used according to the approved indications.Subject is able to read, and comprehend the Informed Consent Document as well as complete the required PROMs in either English or one of the available translations. Exclusion Criteria: 1. The Subject is a woman who is pregnant or lactating. 2. Contralateral knee has already been enrolled in this study. 3. Subject had a contralateral amputation. 4. Subject is currently diagnosed with radicular pain from the spine that radiates into the limb to receive RTKA. 5. Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three (3) months. 6. Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims. 7. Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect his/her ability to complete patient reported questionnaires or be compliant with follow-up requirements. 8. Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia. 9. Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing activities (e.g., muscular dystrophy, multiple sclerosis, Charcot disease). 10. Subject has a medical condition with less than five (5) years life expectancy as determined by the Investigator. 11. Uncontrolled gout

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Revision total knee arthroplasty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Revision total knee arthroplasty

Contacts and locations

Locations

  • Arthroplasty Foundation

    Louisville, Kentucky, 40215, United States

  • Asklepios Orthopädische Klinik Lindenlohe

    Schwandorf in Bayern, Germany

  • CHRU La Cavale Blanche

    Brest, France

  • CLINICHE GAVAZZENI SPA aka Humanitas Castelli

    Bergamo, Italy

  • Centre Hospitalier Universitaire de Rennes

    Rennes, France

  • Chapel Allerton Orthopaedic Centre

    Leeds, United Kingdom

  • Colorado Joint Replacement

    Denver, Colorado, 80210, United States

  • Concordia Joint Replacement

    Winnipeg, Canada

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, 03756, United States

  • Florida Orthopedic Associates

    DeLand, Florida, 32720, United States

  • Fondren Orthopedic Group

    Houston, Texas, 77030, United States

  • Hampshire Hospitals NHS Foundation Trust

    Basingstoke, United Kingdom

  • James Cook University Hospital

    North Yorks, United Kingdom

  • Kantonsspital Baselland (Bruderholz, Liestal, Laufen), Department of Orthopaedic Surgery and Traumatology

    Basel, Switzerland

  • Klinik und Poliklinik für Orthopädie und Sportorthopädie am Klinikum rechts der Isar der Technischen Universität Münche

    Munich, Germany

  • Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.

    Linz, Austria

  • London Health Sciences Centre University Hospital

    London, Ontario, Canada

  • Mery Hospital

    Ozark, Missouri, 65721, United States

  • MoRe Foundation

    Antwerp, Belgium

  • Nuffield Orthopaedic Centre

    Oxford, United Kingdom

  • OrthoCarolina Hip and Knee Center

    Charlotte, North Carolina, 28207, United States

  • Orthopaedic Center of the Rockies

    Fort Collins, Colorado, 80525, United States

  • Orthopedic Partners

    Niantic, Connecticut, 06357, United States

  • Rothman Institute

    Egg Harbor, New Jersey, 08234, United States

  • Scripps Clinic Torrey Pines

    San Diego, California, 92037, United States

  • South Infirmary Public Hospital

    Cork, Ireland

  • Southern Joint Replacement Institute

    Nashville, Tennessee, 37203, United States

  • St. John of God Murdoch Hospital

    Perth, Australia

  • Texas Institute for Hip & Knee Surgery

    Austin, Texas, 78751, United States

  • The Gold Coast Centre for Bone and Joint Surgery

    Gold Coast, Australia

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio, 43210, United States

  • The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust

    Oswestry, United Kingdom

  • UNC Orthopaedics

    Chapel Hill, North Carolina, 27514, United States

  • University Hospital Maastricht

    Maastricht, Netherlands

  • University of Mississippi Medical Center

    Jackson, Mississippi, 39216, United States

  • Victoria Hospital NHS Fife

    Kirkcaldy, United Kingdom

  • Wellington Hospital

    Wellington, New Zealand

  • Wrightington Hospital

    Wigan, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.